APEX Biologix, LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
APEX Biologix, LLC - overview
Location
Murray, UT, US
Primary Industry
Pharmaceuticals
About
Based in Utah, US, and founded in 2014, APEX Biologix, LLC is a designer and manufacturer of regenerative medicine. The company was co-founded by CEO Dan Crane and Business Development manager Brad Unsicker. In 2020, the company launched regenerative products within the veterinarian space. In 2021, Desert Highlands Regenerative acquired a majority stake in APEX Biologix, LLC.
The company operates across North America and employs 11 employees. The company’s product portfolio includes XCELL PRP system such as Benchtop Processing System, Drucker Centrifuge, and Eppendorf Centrifuge, for higher platelet concentration; XCELL BMC to recover a high percentage of total nucleated white blood cells including mesenchymal stem cells and progenitors, from centrifuged bone marrow aspirate; and XCELL PC system as a bone marrow concentration device designed to maximize mesenchymal stem cell (MSC) numbers from bone marrow aspirate. APEX Biologix also offers Amniotic Membrane Patch, a dehydrated human amnion-derived membrane with an intact extracellular matrix that provides structural tissue and an environment for soft tissue reconstruction and regeneration; and RegenVET providing regenerative medicine for veterinarians. Additionally, the company provides PRP kits to scientists and physicians to further their research and services while giving patients the results they need.
Post the acquisition by Desert Highlands Regenerative, the company plans to become a premier leader in regenerative medicine products.
Current Investors
Desert Highlands Regenerative
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.apexbiologix.com
Verticals
Manufacturing
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
APEX Biologix, LLC - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | APEX Biologix, LLC | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.